Ketones for opioid craving study
Part of Hormones & metabolism, Mental health clinical trials.
This trial tests if a ketone supplement can help reduce cravings during opioid withdrawal treatment. Participants take the supplement daily and are monitored for changes in craving and withdrawal symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old
- You have an opioid use disorder and are currently in withdrawal treatment at Caron Treatment Center
- You are willing to follow the study procedures and sign a consent form
- You do not have a serious digestive, liver, or other disease that could interfere with the supplement
- You have not taken GLP-1 medications (like semaglutide) in the past two weeks
- If you could become pregnant, you are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether the medication suvorexant can reduce drug cravings in people with opioid use disorder. You will take either suvorexant or a placebo and have your cravings measured in a safe setting.
This Phase 2 study looks at what opioid withdrawal looks like in the body and whether they can measure it in a meaningful way. You may join if you have an opioid use disorder, can show physical dependence, and are interested in tapering (gradually reducing) opioids under study care.
This study aims to better understand how people experience opioid withdrawal. You will be asked to describe your symptoms, which may help develop a new tool to measure withdrawal more accurately.
This trial tests whether two cannabis-based medicines, dronabinol and Epidiolex, can help ease withdrawal symptoms or cravings in people who have just started buprenorphine for opioid use disorder. It may be a good fit if you are early in treatment and still have symptoms or slip-ups.
This Phase 2 study tests whether buspirone can help reduce symptoms during opioid detox (withdrawal). You may be able to take part if you have opioid withdrawal and are planning medically supervised detox.
This study tests a non-invasive brain stimulation approach to reduce opioid cravings in people who are actively using non-prescribed opioids while on stable methadone. It may help people feel less craving and improve recovery support.
Hear when a new Opioid Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.